Heamocare 120ml

Med-Verified

iron protein succinylate

Quick Summary (TL;DR)

Heamocare 120ml is commonly used for Iron protein succinylate is indicated for the treatment and prevention of iron deficiency anemia and latent iron deficiency states. This includes....

What it's for (Indications)

  • Iron protein succinylate is indicated for the treatment and prevention of iron deficiency anemia and latent iron deficiency states.
  • This includes conditions such as nutritional iron deficiency, increased iron requirements during pregnancy and lactation, periods of rapid growth in infancy and childhood, excessive blood loss due to menstruation or gastrointestinal bleeding, and malabsorption syndromes.
  • It is particularly useful in patients who have experienced gastrointestinal intolerance with other oral iron preparations, as its protein-bound formulation is designed to improve tolerability while effectively replenishing depleted iron stores and supporting erythropoiesis.

Dosage Information

Type Guideline
Standard The typical adult dosage for iron deficiency anemia is 100-200 mg of elemental iron per day, usually administered in one to two divided doses. For children, the dosage should be individualized based on age, weight, and the severity of iron deficiency, generally ranging from 3 to 6 mg/kg/day of elemental iron. Iron protein succinylate is typically taken before or during meals to optimize absorption and minimize gastrointestinal upset. Treatment should continue until hemoglobin levels normalize and iron stores are replenished, which often requires several months of therapy after the hemoglobin concentration returns to normal. It is crucial to follow the specific instructions provided by a healthcare professional.

Safety & Warnings

Common Side Effects

  • Common adverse effects associated with iron protein succinylate, similar to other oral iron preparations, primarily involve the gastrointestinal system.
  • These may include nausea, epigastric pain, abdominal cramps, constipation, or diarrhea.
  • A harmless but common side effect is the blackening of stools, which results from unabsorbed iron and should not be mistaken for melena.
  • Less frequently, patients may experience allergic reactions such as skin rash, pruritus, or, in rare severe cases, anaphylaxis.
  • These symptoms are generally mild and transient; however, if they persist or worsen, medical advice should be sought.
  • Taking the medication with food can sometimes help mitigate gastrointestinal discomfort.

Serious Warnings

  • Black Box Warning: Oral iron preparations, including iron protein succinylate, carry a significant risk of accidental overdose, which is a leading cause of fatal poisoning in children under 6 years of age. Iron overdose can lead to severe systemic toxicity, characterized by five phases: acute gastrointestinal symptoms (nausea, vomiting, abdominal pain, diarrhea, hematemesis), a quiescent period, metabolic acidosis and cardiovascular collapse, hepatic necrosis, and late sequelae including gastrointestinal scarring. It is absolutely imperative to keep iron-containing products, such as iron protein succinylate, out of the sight and reach of children at all times. In the event of suspected iron overdose, immediate medical attention and emergency treatment are critical. Contact a poison control center or emergency services without delay. Prompt intervention, which may include gastric lavage, whole bowel irrigation, and chelation therapy with deferoxamine, is essential to mitigate severe morbidity and mortality.
  • Accurate diagnosis of iron deficiency anemia is essential before initiating iron protein succinylate therapy; it should not be used in anemias not caused by iron deficiency.
  • Patients with pre-existing gastrointestinal conditions such as active peptic ulcers, inflammatory bowel disease, or diverticulitis should use this medication with caution, as iron supplementation may exacerbate these conditions.
  • Iron protein succinylate may interact with certain medications, including antacids, proton pump inhibitors, tetracycline antibiotics, fluoroquinolones, levothyroxine, and bile acid sequestrants, potentially impairing the absorption of either iron or the co-administered drug.
  • It is advisable to separate the administration of iron protein succinylate from these medications by at least 2-4 hours.
  • Patients with hepatic impairment or renal insufficiency should be monitored closely due to potential for altered iron metabolism.
  • As with all medications, keep out of reach of children.
How it Works (Mechanism of Action)
Iron protein succinylate functions as an oral iron supplement, providing elemental iron necessary for erythropoiesis and other vital metabolic processes. The succinylate complex serves as a protective carrier for iron, helping to prevent its premature release in the stomach and thereby reducing local irritation and improving gastrointestinal tolerability compared to traditional iron salts. Upon oral administration, the iron is released from its protein complex in the acidic environment of the stomach, then absorbed primarily in the duodenum and upper jejunum. The absorbed iron is then transported in the bloodstream bound to transferrin to the bone marrow for hemoglobin synthesis, to the liver for storage as ferritin, and to other tissues where it is utilized as a cofactor for various enzymes. By replenishing depleted iron stores, it effectively reverses iron deficiency anemia and its associated symptoms, restoring normal oxygen transport capacity.

Commercial Brands (Alternatives)

AI Safety Note

Found an error? Helping us helps everyone: